{
    "2019-01-04": [
        [
            {
                "time": "2018-12-03",
                "original_text": "Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate",
                "features": {
                    "keywords": [
                        "BMY",
                        "CELG",
                        "MRK",
                        "NASH",
                        "acquisition"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-03",
                "original_text": "Nektar, ImaginAb Enter Into Immuno-Oncology Collaboration",
                "features": {
                    "keywords": [
                        "Nektar",
                        "ImaginAb",
                        "collaboration",
                        "immuno-oncology"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-03",
                "original_text": "Selecta Biosciences Eliminates 36% Of Workforce",
                "features": {
                    "keywords": [
                        "Selecta Biosciences",
                        "workforce reduction",
                        "cost-cutting"
                    ],
                    "sentiment_score": -0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}